Late Urinary Toxicity After Extreme or Moderate Hypofractionated Prostate Radiation Therapy in Patients With Prior Transurethral Resection of Prostate
Maneesh Singh(University of Liège), Vedang Murthy(Homi Bhabha National Institute), Gagan Prakash(Homi Bhabha National Institute), Priyamvada Maitre(Homi Bhabha National Institute), Ganesh Bakshi(P. D. Hinduja Hospital and Medical Research Centre), Sarath Mini Sreekumar, Ketaki Adsul, Reena Phurailatpam(Tata Memorial Hospital), Divya Kamble, Pranav Narayan Bishnu, Harshdeep Chauhan, Anuradha Krishnan, Ankit Misra(Homi Bhabha National Institute), Pallavi Singh, Mahendra Pal(Homi Bhabha National Institute), Amandeep Arora(Homi Bhabha National Institute)
International Journal of Radiation Oncology*Biology*Physics
June 20, 2024
Cited by 10
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340